Novanta Inc., provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company is headquartered in Bedford, Massachusetts.
| Revenue (TTM) | $1.00B |
| Gross Profit (TTM) | $444.51M |
| EBITDA | $178.81M |
| Operating Margin | 11.70% |
| Return on Equity | 5.16% |
| Return on Assets | 4.56% |
| Revenue/Share (TTM) | $26.66 |
| Book Value | $36.81 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -13.40% |
| Quarterly Revenue Growth (YoY) | 10.40% |
| Shares Outstanding | 0 |
| Float | $35.32M |
| % Insiders | 0.00% |
| % Institutions | 98.17% |
Volatility is currently expanding